MaxCyte, Inc.
MXCT
$1.27
$0.032.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.05M | 32.29M | 33.03M | 34.42M | 35.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.05M | 32.29M | 33.03M | 34.42M | 35.75M |
| Cost of Revenue | 6.45M | 6.29M | 6.22M | 6.89M | 7.23M |
| Gross Profit | 24.60M | 25.99M | 26.80M | 27.53M | 28.53M |
| SG&A Expenses | 38.22M | 41.46M | 46.29M | 51.57M | 55.56M |
| Depreciation & Amortization | 4.05M | 4.18M | 4.23M | 4.21M | 4.18M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.48M | 70.71M | 77.56M | 84.77M | 89.07M |
| Operating Income | -34.43M | -38.42M | -44.53M | -50.35M | -53.31M |
| Income Before Tax | -35.64M | -39.12M | -44.63M | -45.63M | -44.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.64 | -39.12 | -44.63 | -45.63 | -44.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.64M | -39.12M | -44.63M | -45.63M | -44.77M |
| EBIT | -34.43M | -38.42M | -44.53M | -50.35M | -53.31M |
| EBITDA | -30.28M | -34.15M | -40.21M | -46.03M | -48.99M |
| EPS Basic | -0.33 | -0.37 | -0.42 | -0.43 | -0.42 |
| Normalized Basic EPS | -0.17 | -0.19 | -0.22 | -0.25 | -0.26 |
| EPS Diluted | -0.33 | -0.37 | -0.42 | -0.43 | -0.42 |
| Normalized Diluted EPS | -0.17 | -0.19 | -0.22 | -0.25 | -0.26 |
| Average Basic Shares Outstanding | 427.04M | 426.63M | 425.70M | 424.51M | 423.01M |
| Average Diluted Shares Outstanding | 427.04M | 426.63M | 425.70M | 424.51M | 423.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |